Women have higher risk for solicited reactions after flu shot
Sep 29, 2023
Women have a higher risk for injection site reactions, systemic reactions and severe reactions.
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
COVID-19 certification mandates may increase vaccine uptake
Dec 22, 2021
Country-specific information, such as prior vaccination uptake and vaccine hesitancy, may influence the effect of COVID-19 certification mandates.
FDA adds Guillain-Barré warning to J&J COVID-19 vaccine
Jul 12, 2021
Approximately 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered.
FDA approves Capvaxive pneumococcal 21-valent conjugate vaccine
Jun 21, 2024
Merck says the vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults aged 50 or more years.
Allergic reactions to mRNA COVID-19 vaccines characterized
Sep 20, 2021
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria.
In 11 states, seniors’ low vaccination rates a ‘powder keg’ for new cases
Jun 21, 2021
In states where vaccination rates are low, seniors who have not gotten a shot pose a public health risk as social-distancing restrictions are stripped away.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
One in nine may get delayed large local reaction after Moderna vaccine
Jun 10, 2022
A higher risk was seen among women and among individuals aged 30 to 69 years.
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.